Newsletters

Dear All (and with thanks to Robert Skov for co-authoring this newsletter AND with a wonkish alert for this complicated ...

Dear All, I’m delighted to be able to say that PASTEUR 2026 was (re)introduced into the US Congress this week! ...

Dear All, In a thoughtful companion to WHO’s preclinical and clinical pipeline reviews, we now have an instructive analysis of ...

Dear All, I just today learned that FDA has posted two antimicrobial resistance-related (AMR-related) FY 2026 funding opportunities. The titles ...

Dear All, Happy New Year! As a great start for January, Team CARB-X have announced (i) that they will have two ...

Dear All, Regular readers will be aware of the global conversation now happening around the threat arising from the potential ...

Dear All, In a paper that is clearly a labor of love (1,032 references!), Mark Butler and Robert Capon have ...

Note: As always, please use the copy of the newsletter posted at https://amr.solutions/ if you have trouble with links in this ...

Dear All, The 8 Dec 2025 newsletter entitled “Phage therapy: Regulatory perspectives from TATFAR” generated a fair bit of commentary! ...

Dear All, Integrating perspectives from EC HERA, EMA, Health Canada, Norway, UK MHRA, US FDA, and US NIH, the Transatlantic ...

Dear All, On 26 Nov 2026, the Antimicrobial Resistance Surveillance & Research Initiative (AMRSRN) of the Indian Council on Medical Research ...

Dear All, Recently posted, six concepts were approved for FY 2027 funding at the September 2025 meeting of NIAID’s Division of Microbiology and ...

Dear All, I’ve written in the past about the creative work done by the Milken Institute on health care financing ...

Dear All, I wrote in the 4 Oct 2025 newsletter about WHO’s updated reviews of antibacterial therapeutics and diagnostics. Team WHO have ...

Dear All, When I wrote earlier this year (23 Jan 2025 newsletter) that the January 2025 PACCARB meeting (Presidential Advisory ...

Dear All, I wrote previously (23 Sep 2025 newsletter, “EU’s €253 million, 10-year One Health AMR (OHAMR) Initiative”) about OHAMR (European ...